Comparison of Clinical Characteristics of Patients With Rheumatoid Arthritis (RA) Identified By Physicians As Potentially Suitable For Biosimilar Infliximab Versus Those Who Were Not Considered Biosimilar Infliximab Suitable In Europe (EU)
May 1, 2015, 00:00
10.1016/j.jval.2015.03.969
https://www.valueinhealthjournal.com/article/S1098-3015(15)01026-8/fulltext
Title :
Comparison of Clinical Characteristics of Patients With Rheumatoid Arthritis (RA) Identified By Physicians As Potentially Suitable For Biosimilar Infliximab Versus Those Who Were Not Considered Biosimilar Infliximab Suitable In Europe (EU)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)01026-8&doi=10.1016/j.jval.2015.03.969
First page :
A167
Section Title :
Muscular-Skeletal Disorders
Open access? :
No
Section Order :
411